Analyst Consensus ?
ConsensusBuy22 ratings
Bullish1881.8%
Neutral418.2%
Bearish00.0%
FN2 Earnings Intelligence
Axon Enterprise, Inc. analyst ratings
Axon Enterprise, Inc. (AXON) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$479.34Current
$300Low
$663.7Average
$900High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 13, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Sep 3, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 6, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| Needham | Buy | Buy | Maintain | Jul 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jun 25, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 7, 2026 |
| TD Cowen | Buy | Buy | Maintain | Apr 8, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 8, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 25, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Sep 29, 2025 |
| B of A Securities | Buy | Buy | Maintain | Aug 6, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Northland Capital Markets | Outperform | Outperform | Maintain | Aug 5, 2025 |
| Craig-Hallum | Buy | Hold | Upgrade | Aug 5, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Feb 26, 2025 |
| Baird | Outperform | Outperform | Maintain | Dec 6, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | May 10, 2023 |
| Imperial Capital | In Line | In Line | Maintain | May 18, 2020 |
| Ladenburg Thalmann | Neutral | Buy | Downgrade | Oct 15, 2018 |
| CL King | Neutral | Buy | Downgrade | Mar 16, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $479.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Analyst unavailable | $600 | $506.98 | +25.2% | Sep 3, 2026 |
| Morgan Stanley | Meta Marshall | $640 | $528.41 | +33.5% | Aug 6, 2026 |
| Goldman Sachs | Analyst unavailable | $715 | $561.47 | +49.2% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $732 | $551.4 | +52.7% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $688 | $609.49 | +43.5% | Aug 6, 2026 |
| Piper Sandler | Analyst unavailable | $724 | $565.8 | +51.0% | Jul 13, 2026 |
| Needham | Analyst unavailable | $750 | $597.04 | +56.5% | Jul 6, 2026 |
| Piper Sandler | James Fish | $674 | $457.33 | +40.6% | Jun 15, 2026 |
| Barclays | Tim Long | $523 | $426.89 | +9.1% | May 8, 2026 |
| Morgan Stanley | Analyst unavailable | $600 | $433.82 | +25.2% | May 7, 2026 |
| Goldman Sachs | Analyst unavailable | $535 | $434.5 | +11.6% | May 7, 2026 |
| UBS | Analyst unavailable | $440 | $416.57 | -8.2% | May 7, 2026 |
| Morgan Stanley | Analyst unavailable | $675 | $391.53 | +40.8% | Apr 8, 2026 |
| Goldman Sachs | Analyst unavailable | $625 | $391.53 | +30.4% | Apr 8, 2026 |
| Robert W. Baird | Analyst unavailable | $800 | $523.63 | +66.9% | Feb 25, 2026 |
| Craig-Hallum | Jeremy Hamblin | $820 | $543.47 | +71.1% | Feb 25, 2026 |
| RBC Capital | David Paige | $735 | $543.24 | +53.3% | Feb 25, 2026 |
| Piper Sandler | James Fish | $690 | $548.22 | +43.9% | Feb 25, 2026 |
| Northcoast Research | Keith Housum | $742 | $591.16 | +54.8% | Jan 6, 2026 |
| Morgan Stanley | Meta Marshall | $713 | $555.06 | +48.7% | Dec 17, 2025 |
| RBC Capital | Analyst unavailable | $860 | $554.37 | +79.4% | Nov 17, 2025 |
| Piper Sandler | James Fish | $753 | $622.38 | +57.1% | Nov 5, 2025 |
| Raymond James | Analyst unavailable | $855 | $867.12 | +78.4% | Aug 5, 2025 |
| Northland Securities | Michael Latimore | $800 | $867.12 | +66.9% | Aug 5, 2025 |
| Needham | Joshua Reilly | $870 | $867.12 | +81.5% | Aug 5, 2025 |
| UBS | Analyst unavailable | $840 | $867.12 | +75.2% | Aug 5, 2025 |
| Craig-Hallum | Analyst unavailable | $900 | $867.12 | +87.8% | Aug 5, 2025 |
| Morgan Stanley | Meta Marshall | $885 | $729.62 | +84.6% | Jul 11, 2025 |
| Barclays | Analyst unavailable | $726 | $506.96 | +51.5% | Feb 27, 2025 |
| Morgan Stanley | Meta Marshall | $700 | $636.39 | +46.0% | Dec 3, 2024 |
| Needham | Joshua Reilly | $525 | $443.98 | +9.5% | Oct 22, 2024 |
| Goldman Sachs | Michael Ng | $441 | $443.98 | -8.0% | Oct 22, 2024 |
| Robert W. Baird | William Power | $400 | $364.39 | -16.6% | Sep 10, 2024 |
| Craig-Hallum | Jeremy Hamblin | $370 | $315.35 | -22.8% | May 7, 2024 |
| Needham | Joshua Reilly | $400 | $311.27 | -16.6% | Apr 10, 2024 |
| Argus Research | John Staszak | $380 | $306.78 | -20.7% | Mar 13, 2024 |
| Credit Suisse | Sami Badri | $300 | $225.13 | -37.4% | Apr 11, 2023 |
| Morgan Stanley | Analyst unavailable | $155 | $168.59 | -67.7% | Dec 13, 2022 |
Track every rating change on AXON the moment it posts. Free to start.
Start free